RevitalVision

Neurological Treatment for Vision Disorders

Startup

RevitalVision is a Modi'in-Maccabim-Re'ut-based startup in the Health Tech & Life Sciences sector, established in 2019. Neurological Treatment for Vision Disorders. The company has raised a total of $3.7M across 3 funding rounds, currently at the Seed stage. RevitalVision was founded by Yair (Gottlieb) Yahav. Key investors include PipelBiz. The company has 11-50 employees. Core technologies: Artificial Intelligence, Computer Vision.

With $3.7M in total funding, RevitalVision is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Released. The company holds 1 patent.

$3.7M
Raised
3
Rounds
1
Investors
5
Team
2019
Founded
1
Patents
Sector & Technology
Health Tech & Life SciencesDigital HealthcareDigital TherapeuticsArtificial IntelligenceComputer Vision
At a Glance
Investors
Founders
In the News

5 articles covered by sources including en.globes.co.il, www.geektime.co.il, www.globes.co.il, www.calcalistech.com, www.healio.com.

en.globes.co.il · Apr 15, 2024
RevitalVision announces success in new trial
Read article ↗
Frequently Asked Questions
What does RevitalVision do?

RevitalVision is a SaaS-based digital health startup operating in the rapidly growing, $52 billion field of vision improvement in the ophthalmic marketplace. The company’s noninvasive technology enhances eyesight neurologically, offering an innovative solution to the 500 million people whose needs are unmet by existing vision treatments. RevitalVision’s thousands of clinical trial participants and commercial customers have reported and exhibited significant improvement in their vision performance by 2.5 lines on the visual acuity eye chart along with a 100% increase in contrast sensitivity on average for all product categories. RevitalVision is FDA-cleared for children older than 9 and adults with amblyopia (lazy eye), a leading cause of vision impairment that affects 3% to 5% of the world population. Using brain science and proprietary algorithm-based technology, RevitalVision is clinically validated for use for multiple eye diseases and vision impairments and has been approved for two new unique reimbursement codes by the American Medical Association for the treatment of amblyopia. RevitalVision provides eye care specialists with a simple, easy-to-use tool to improve patients’ vision beyond optical correction and other current eye treatments, as well as an additional revenue channel. The company also offers eye surgery clinics a valuable tool for reducing unpaid post-surgery visits by cataract and refractive patients who find it difficult to neuro-adapt or who suffer from reduced contrast sensitivity, poor night vision, or side effects such as halo and glare.

How much funding has RevitalVision raised?

RevitalVision has raised $3.7M in total funding across 3 rounds. The company is currently at the Seed stage. Key investors include PipelBiz.

Who founded RevitalVision?

RevitalVision was founded in 2019 by Yair (Gottlieb) Yahav (CEO).

What sector is RevitalVision in?

RevitalVision operates in Health Tech & Life Sciences, Digital Healthcare, Digital Therapeutics, with core technologies in Artificial Intelligence, Computer Vision. Target customers: Healthcare & Life Sciences, Healthcare, Patients, Providers, Consumers, Recreational & Lifestyle, Fitness & Sports, Demographics & Family, Seniors.

Where is RevitalVision located?

RevitalVision is based in HaMa'ayan Street 2, Modi'in-Maccabim-Re'ut, Israel, Center District.

View Full Profile Classic View Website ↗